Skip to content

Immunovant

US · IMVT #1790 by market cap Listed 2017
31.77 -0.75 -2.31%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
C-
Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 8 analysts

Buy
Avg price target 48.43 +52.4%
Price target rangecurrent 31.77
Low37.00
Avg48.43
High66.00
Buy 75% Hold 25% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-12 J.P. Morgan -- Buy 49.00
2026-11-10 Wells Fargo -- Buy 47.00
2026-11-10 H.C. Wainwright -- Buy 41.00
2026-11-09 Wells Fargo -- Buy 47.00
2026-11-09 BofA Securities -- Buy 46.00
2026-10-16 Wells Fargo -- Buy 45.00
2026-10-12 BofA Securities -- Buy 45.00
2026-09-26 LifeSci Capital -- Buy 53.00
2026-09-25 Bernstein -- Hold 37.00
2026-09-24 Truist Financial -- Hold --
2026-09-23 LifeSci Capital -- Buy 53.00
2026-09-23 H.C. Wainwright -- Buy 41.00
2026-09-21 Piper Sandler -- Buy 66.00
2026-08-11 Stifel -- Buy 57.00
2026-08-10 H.C. Wainwright -- Buy 41.00
2026-08-10 J.P. Morgan -- Buy 50.00
2026-08-07 LifeSci Capital -- Buy 53.00
2026-08-07 Piper Sandler -- Buy 66.00
2026-08-07 BofA Securities -- Buy 45.00
2026-08-07 H.C. Wainwright -- Buy 41.00
2026-08-07 Oppenheimer -- Buy 54.00
2026-08-04 J.P. Morgan -- Buy 50.00
2026-07-11 LifeSci Capital -- Buy 53.00
2026-07-09 LifeSci Capital -- Buy 53.00
2026-06-30 Citi -- Buy 61.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2027/Q2 2026-11-09 -- ±11.59% +15.13% (beat)
2027/Q1 2026-08-06 -- ±11.67% +1.17% (in line)
2026/Q4 2026-05-20 -- ±18.64% +35.26% (beat)
2026/Q3 2026-02-06 -- ±14.44% +12.43% (in line)
2026/Q2 2025-11-10 -- ±16.37% +0.09% (in line)
2025/Q2 2024-11-07 -- ±13.27% -4.74% (in line)
2022/Q4 2022-06-08 -- ±28.10% -8.20% (in line)
2022/Q1 2021-08-09 -- ±19.72% +0.39% (in line)
2021/Q4 2021-06-01 -- ±21.01% -37.99% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Immunovant discussion 0 comments

Add a comment